Episcleritis Related to Drug-Induced Lupus Erythematosus following Infliximab Therapy: A Case Report | Zendy

Irini Chatziralli | Zendy; Evgenia Kaidou | Zendy; Alexandros Chatzirallis | Zendy; Prodromos Dimitriadis | Zendy; Petros Keryttopoulos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Episcleritis Related to Drug-Induced Lupus Erythematosus following Infliximab Therapy: A Case Report

Author(s) -

Irini Chatziralli,

Evgenia Kaidou,

Alexandros Chatzirallis,

Prodromos Dimitriadis,

Petros Keryttopoulos

Publication year - 2011

Publication title -

case reports in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.2

H-Index - 20

eISSN - 1687-9627

pISSN - 1687-9635

DOI - 10.1155/2011/696285

Subject(s) - medicine , episcleritis , discontinuation , systemic lupus erythematosus , infliximab , drug , dermatology , lupus erythematosus , immunology , tumor necrosis factor alpha , disease , scleritis , pharmacology , antibody , uveitis

Drug-induced lupus erythematosus is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation of the offending drug. Herein, we describe a patient with distinct clinical manifestations of anti-TNF-associated DILE related to infliximab therapy. The patient exhibited clinical and laboratory findings of lupus-like illnesses as well as ocular disorders, such as episcleritis. The main message is that the symptoms of DILE should not be overlooked, although sometimes other systematic conditions may underlie them. As a result, it is very important for the clinicians to evaluate the symptoms of DILE and manage appropriately these cases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research